Australia markets close in 1 hour 36 minutes

Anteris Technologies Ltd (AVR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
17.73-0.18 (-1.01%)
As of 02:04PM AEST. Market open.
Full screen
Previous close17.91
Open18.00
Bid17.73 x N/A
Ask17.87 x N/A
Day's range17.73 - 18.10
52-week range15.58 - 23.93
Volume2,848
Avg. volume9,195
Market cap340.811M
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
EPS (TTM)-4.31
Earnings date23 Aug 2024 - 27 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est30.00
  • Business Wire

    Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

    BRISBANE, Australia & EAGAN, Minn., July 01, 2024--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, and v2vmedtech, inc., a structural heart company developing a next generation Transcatheter Edge to Edge Repair (TEER) system for mitral and tricuspid valve regurgitation today announced they have reached concep

  • Business Wire

    Anteris Provides Update on DurAVR™ THV Valve-in-Valve Experience Presented at New York Valves 2024

    BRISBANE, Australia & EAGAN, Minn., June 13, 2024--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, today announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.

  • Business Wire

    Anteris Provides Data Update on First in Human Study of DurAVR™ THV Presented at New York Valves 2024

    BRISBANE, Australia & MINNEAPOLIS, June 11, 2024--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVI and the world’s only balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, today announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.